The primary endpoint of death and non-fatal heart attack at 30 days was no different between the two groups (7 percent in the aspirin group and 7.1 percent in the placebo group); however, major bleeding was significantly higher in aspirin - treated
patients than in the placebo group (4.6 percent vs. 3.7 percent).
Between August 2012 and June 2015, 27 percent fewer women in the dapivirine ring group were infected with
HIV than in the placebo group, the study's authors found.
An interesting study reported in The Journal of Biobehavioral Medicine observed that subjects exposed to a stressor and also given a 600 mg dose of lemon balm rated their calmness significantly
higher than those in a placebo group.
These improvements, he said, resulted in a greater reduction in net use of blood pressure drugs and lipid - lowering medications in the liraglutide 3 mg group
than in the placebo group.
A significantly higher percentage of patients receiving pinaverium reported that their IBS symptoms improved (60 percent)
than in the placebo group (34 percent).
The average total hip BMD increased more in the treatment group
than in the placebo group both at 12 months (2.8 percent vs. -0.5 percent) and at 24 months (2.6 percent vs. -1.5 percent), according to the results.
The cinnamon group had a significantly better reduction of fasting glucose (10.3 %)
than in the placebo group (3.4 %).
Change in the HAM - D - 24 (improvement) was greater in the fluoxetine group
than in the placebo group (− 6 v − 2, p < 0.05).
The mean total number of drinks consumed during the 12 week trial was lower in the fluoxetine group
than in the placebo group (70 v 216, p < 0.03) as was the mean number of days on which alcoholic drinks were consumed during the trial (11 v 20, p < 0.05).